Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06435858Phase 2Completed
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease
PrincipalinvestigatorStart date: 2024-09-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cantonal Hospital Graubuenden

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vimal Derebail, MD, MPH

University of North Carolina, Chapel Hill

Moderately Similar
2 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Kültigin Türkmen, Fellow

Istanbul University Istanbul Medical Faculty Department of Internal Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Marva Moxey-Mims, M.D.

NIH, NIDDK, DKUH

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Tevfik Ecder, Professor

Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Eiji Higashihara, MD

Kyorin University School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Hélène François, MD, PhD

Assistance Publique - Hôpitaux de Paris

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Eiji Higashihara, M.D.

Kyorin University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Rian Dişçi, Professor

Istanbul University Istanbul Medical Faculty Department of Public Health

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Priya Velu, MD, PhD

Weill Medical College of Cornell University

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Erling B Pedersen

Department of Medical Research and Medicine, Holstebro Regional Hospital Holstebro, Holstebro, Denmark, 7500

Moderately Similar
1 trials

Shared therapeutic areas:

Autosomal Dominant Polycystic Kidney Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06435858Phase 2PrincipalInvestigator

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease
Completed

All 1 trials loaded